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The purpose of this study was to clarify,  through a prospective study,  the relationship between leptin 
and adiponectin levels,  and subsequent weight change.  The study subjects were 2,485 male oﬃce 
workers aged 35-64 employed by a company in Fukuoka Prefecture,  Japan.  Of these men,  1,936 
(77.9ｵ) received health check-ups both in 2005-2007 and 3 years later,  in 2008-2010.  Of the subjects 
who received both health check-ups,  352 were excluded duo to cancer,  cardiac infarction,  stroke or 
diabetes mellitus,  leaving a total of 1,584.  We divided them into tertiles according to baseline leptin and 
adiponectin levels,  and compared the subsequent change in body mass index (BMI) over 3 years.  The 
subjects with the lowest leptin levels showed a signiﬁcantly greater increase in BMI (diﬀerence in 
change in BMI＝0.178kg/m2,  95ｵ CI: 0.025-0.331kg/m2) over 3 years when those with the highest 
leptin levels were regarded as the reference even after adjusting for age,  baseline BMI,  smoking sta-
tus,  drinking status and exercise.  The subjects with the highest adiponectin levels showed a greater 
increase in BMI (diﬀerence in change in BMI＝0.099kg/m2,  95ｵ CI: －0.034-0.231kg/m2) over 3 years 
when those with the lowest adiponectin levels were regarded as the reference,  but this association was 
not statistically signiﬁcant after adjusting for age,  baseline BMI,  smoking status,  drinking status and 
exercise.  Our ﬁndings suggest that higher leptin levels may suppress weight gain in Japanese male 
workers.
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ecently,  the World Health Organization reported 
that more than 1.4 billion adults aged 20 or over 
were overweight.  Of these over 200 million men and 
nearly 300 million women were obese.  Worldwide 
obesity has more than doubled since 1980 [World 
Health Organization.  Obesity and overweight.  Available 
from<http://www.who.int/mediacentre/factsheets/
fs311/en/>].  Japan has the lowest level of obesity,  
but the proportion of those overweight has shown a 
continuously increasing trend in men (from 15.2ｵ in 
1976 to 30.3ｵ in 2011) [1],  [Ministry of Health,  
labour and welfare of Japan.  The national health and 
nutrition survey in Japan,  2011.  Available from 
<http://www.mhlw.go.jp/bunya/kenkou/eiyou/dl/
h23-houkoku-05.pdf>].  Obese people are at risk for 
diabetes mellitus,  ischemic heart disease,  stroke,  and 
certain cancers.  Obesity is a worldwide health issue.
　 Adipose tissue was long considered passive tissue 
that specializes in energy storage,  but recent research 
has demonstrated that it produces and secretes various 
bioactive substances,  which are known as adipocytok-
ines [2-8].  Leptin is an adipocyte-derived protein 
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that acts on the hypothalamus to regulate appetite and 
energy expenditure [2,  3].  Adiponectin is another 
adipocyte-derived protein,  and adiponectin levels are 
lower in the obese than in the non-obese [4].  
Hypoadiponectinemia was found to be signiﬁcantly and 
independently associated with diabetes mellitus type 2,  
metabolic syndrome,  and cardiovascular diseases [5,  
6,  8].  Kubota et al.  reported that adiponectin stimu-
lates food intake and decreases energy expenditure 
during fasting through its eﬀects on the central ner-
vous system,  and suggested that the fundamental roles 
of leptin and adiponectin are to preserve an adequate 
fat reserve: leptin acts as a satiety signal,  and adi-
ponectin acts as a starvation signal [9].  Therefore,  it 
is of interest to examine the relationship beween leptin 
and adiponectin levels,  and subsequent weight change.
　 Many prospective studies have been conducted to 
clarify the relationship between leptin and adiponectin 
levels,  and subsequent weight change,  but the results 
were inconsistent [10-18].  Some studies showed a 
positive association between leptin levels and subse-
quent weight change [10,  11],  while others found no 
association or an inverse association [12-15].  One 
study found that high adiponectin levels were associ-
ated with signiﬁcantly greater weight gain [16],  but 
others showed no association between adiponectin 
levels and subsequent weight change [14,  17,  18].
　 Many of these previous prospective studies were 
conducted in the United States,  where among adults 
aged 20 or over,  69.2ｵ were overweight and 35.9ｵ 
were obese [19].  To the best of our knowledge,  there 
has been no previous prospective study on the rela-
tionship between leptin and adiponectin levels,  and 
subsequent weight change in Japan,  where the preva-
lence of obesity is much lower; the overweight and 
obese accounted for 30.3ｵ and 4.6ｵ,  respectively,  
among men aged 20 or over in 2011 [Ministry of 
Health,  labour and welfare of Japan.  The national 
health and nutrition survey in Japan,  2011.  Available 
from<http://www.mhlw.go.jp/bunya/kenkou/eiyou/
dl/h23-houkoku-05.pdf>].
　 We conducted a prospective study to clarify the 
relationship between leptin and adiponectin levels,  and 
subsequent weight change over 3 years in Japanese 
male workers aged 35 to 64.
Materials and Methods
　 The study subjects were 2,485 male oﬃce workers 
aged 35-64 employed by a company in Fukuoka 
Prefecture,  Japan.  Of these,  2,360 received health 
check-ups in 2005-2007 (baseline).  Of these 2,360,  
322 men retired or resigned in the 3 years between 
2005-2007 (baseline) and 2008-2010 (endpoint),  and 
102 did not have endpoint health check-ups.  Thus,  of 
the initial 2,485 men,  1,936 (77.9ｵ) received both 
baseline and endpoint health check-ups,  and had their 
leptin and adiponectin levels measured at baseline.  
The endpoint health check-ups were carried out in the 
morning of the same calendar month as the baseline 
health check-ups 3 years earlier.  We excluded 352 
men from the analysis because they had a history of 
cancer,  cardiac infarction or stroke,  or had received 
treatment for diabetes mellitus,  or had a hemoglobin 
A1c (HbA1c) level of 6.5ｵ or more at the 
endpoint; thus,  we analyzed a total of 1,584 men.  We 
collected information on their smoking status,  drink-
ing status and exercise by self-administered question-
naire at the endpoint and measured height without 
footwear and weight in light clothing at the baseline 
and the endpoint.  Body mass index (BMI) was calcu-
lated as weight (kg) divided by height (m) squared.
　 Leptin and adiponectin levels were determined 
immediately after drawing blood.  All subjects agreed 
to have their serum leptin and adiponectin levels 
measured.  The level of serum leptin was evaluated by 
enzyme immunoassay (Human Leptin RIA Kit; Linco 
Research,  St. Charles,  MO,  USA) and that of serum 
adiponectin was determined by enzyme-linked immuno-
sorbent assay (Otsuka Pharmaceutical Co.,  Ltd,  
Tokushima,  Japan).  HbA1c was measured by latex 
agglutination using a commercially available kit (Fuji 
Rebio,  Tokyo,  Japan).  In order to obtain measure-
ments equivalent in value to those used by the US 
National Glycohemoglobin Standardization Program 
(NGSP),  we added 0.4 to the value of HbA1c,  because 
HbA1c values measured in Japan are 0.4 lower than 
NGSP measurements [20].
　 For the purpose of the present study,  serum leptin 
and serum adiponectin levels were divided into ter-
tiles.  The tertile points were 2.1ng/mL and 3.4ng/
mL for leptin,  and 5.1µg/mL and 7.4µg/mL for adi-
ponectin.  We divided smoking status into 3 categories 
(current smokers,  ex-smokers and never-smokers),  
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alcohol status into 3 categories (regular drinkers,  
occasional drinkers and non-drinkers),  and exercise 
into 2 categories (exercise positive: exercise for more 
than 30min at a time and more than twice a week;  
exercise negative: less than exercise positive).
　 Associations between the tertiles of leptin and 
adiponectin levels,  and the various factors under 
consideration were analyzed by one-way analysis of 
variance (ANOVA) or the Kruskal-Wallis rank sum 
test for continuous variables and by chi-square test for 
categorical variables.  Analysis of covariance 
(ANCOVA) was conducted using the diﬀerence in 
change in BMI over 3 years as a dependent variable,  
and the tertiles of leptin levels and of adiponectin 
levels as main predictive variables,  with age (continu-
ous variable),  smoking status,  drinking status,  exer-
cise and BMI at baseline as covariates.  All analyses 
were performed using the Statistical Analysis System,  
Version 9.1 (SAS Institute,  Cary,  NC,  USA).
　 The study protocol was approved by the Ethics 
Committee of Fukuoka University and written 
informed consent was obtained from each participant.
Results
　 Lifestyle factors and age distribution accord-
ing to leptin and adiponectin levels. Lifestyle 
factors and age distribution are shown in Tables 1 and 
2 according to leptin and adiponectin levels,  respec-
tively.  Both leptin and adiponectin levels were sig-
niﬁcantly associated with age,  and were not signiﬁ-
cantly associated with drinking status or exercise.  
Smoking status was signiﬁcantly related to leptin 
levels,  but not adiponectin levels.
　 Average of BMI and change in BMI over 
three years according to leptin and adiponectin 
levels. Average of height,  BMI at baseline and at 
endpoint and change in BMI over 3 years,  and range 
of BMI at baseline are shown in Table 3 and Table 4 
according to leptin and adiponectin levels,  respec-
tively.
　 Leptin levels showed a signiﬁcant positive associa-
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Table 1　 Lifestyle factors and age distribution according to leptin levels
Variables
Tertile 1 Tertile 2 Tertile 3
P value
(n＝538) (n＝519) (n＝527)
Mean leptin value (ng/mL) 1.45 2.67 5.24
Mean age (years) 47.1 47.2 46.2 0.015＄
Age (years)
　35-44 216 (40.2) 200 (38.5) 238 (45.2) 0.048
　45-54 237 (44.1) 253 (48.8) 231 (43.8)
　55-64  85 (15.8)  66 (12.7)  58 (11.0)
Smoking status
　Current smokers 346 (64.3) 302 (58.2) 257 (48.8) ＜0.001
　Ex-smokers  72 (13.4)  95 (18.3) 106 (20.1)
　Never-smokers 120 (22.3) 122 (23.5) 164 (31.1)
Drinking status
　Regular drinkers 298 (55.4) 283 (54.5) 274 (52.0) 0.839
　Occasional drinkers 139 (25.8) 140 (27.0) 148 (28.1)
　Non-drinkers 101 (18.8)  96 (18.5) 105 (19.9)
Exercise
　Positive 121 (22.5) 108 (20.8)  97 (18.4) 0.254
　Negative 417 (77.5) 411 (79.2) 430 (81.6)
Leptin level of tertile 1,  ＜2.1ng/mL; Leptin level of tertile 2,  2.1-3.3ng/mL; Leptin level of tertile 3,  ｧ3.4ng/mL; Numbers in parenthe-
ses are percentages.  Exercise: exercise for more than 30min at a time and more than twice a week (exercise positive) and less than that 
(exercise negative).
＄: the Kruskal-Wallis rank sum test was used.
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Table 4　 Average BMI and change in BMI over three years according to adiponectin levels
Variables Tertile 1 (n＝535) Tertile 2 (n＝522) Tertile 3 (n＝527) P value
Height at baseline,  mean±SD (cm) 169.6±5.8 169.5±6.1 169.3±6.0 0.588
BMI at baseline,  mean±SD (kg/m2) 24.98±3.02 23.97±3.02 22.26±2.98 ＜0.001
Range of BMI at baseline (kg/m2) 16.9-38.4 15.0-35.5 14.9-37.2
BMI at endpoint,  mean±SD (kg/m2) 25.07±3.15 24.11±3.08 22.53±2.99 ＜0.001
Change of BMI over three years,  mean±SD (kg/m2) 0.09±1.06 0.14±1.06 0.27±0.97 ＜0.014
Adiponectin level of tertile 1,  ＜5.1µg/mL; Adiponectin level of tertile 2,  5.1-7.3µg/mL; Adiponectin level of tertile 3,  ｧ7.4µg/mL;  
BMI,  body mass index; SD,  standard deviation; P values were calculated by one-way analysis of variance.
Table 3　 Average BMI and change in BMI over three years according to leptin levels
Variables Tertile 1 (n＝538) Tertile 2 (n＝519) Tertile 3 (n＝527) P value
Height at baseline,  mean±SD (cm) 169.1±6.1 169.4±6.0 169.8±5.7 0.158
BMI at baseline,  mean±SD (kg/m2) 21.59±2.41 23.52±2.33 26.16±3.00 ＜0.001
Range of BMI at baseline (kg/m2) 15.0-28.4 14.9-31.3 17.5-38.4
BMI at endpoint,  mean±SD (kg/m2) 21.88±2.53 23.74±2.41 26.15±3.19 ＜0.001
Change of BMI over three years,  mean±SD (kg/m2) 0.29±0.94 0.22±0.97 －0.01±1.16 ＜0.001
Leptin level of tertile 1,  ＜2.1ng/mL; Leptin level of tertile 2,  2.1-3.3ng/mL; Leptin level of tertile 3,  ｧ3.4ng/mL; BMI,  body mass 
index; SD,  standard deviation; P values were calculated by one-way analysis of variance.
Table 2　 Lifestyle factors and age distribution according to adiponectin levels
Variables
Tertile 1 Tertile 2 Tertile 3
P value
(n＝535) (n＝522) (n＝527)
Mean adiponectin value (µg/mL) 3.92 6.15 10.39
Mean age (years) 46.1 46.8 47.6 ＜0.01＄
Age (years)
　35-44 250 (46.7) 212 (40.6) 192 (36.4) ＜0.001
　45-54 237 (44.3) 239 (45.8) 245 (46.5)
　55-64  48 ( 9.0)  71 (13.6)  90 (17.1)
Smoking status
　Current smokers 317 (59.3) 303 (58.1) 285 (54.1) 0.077
　Ex-smokers  77 (14.4) 101 (19.4)  95 (18.0)
　Never-smokers 141 (26.4) 118 (22.6) 147 (27.9)
Drinking status
　Regular drinkers 295 (55.1) 278 (53.3) 282 (53.5) 0.942
　Occasional drinkers 137 (25.6) 145 (27.8) 145 (27.5)
　Non-drinkers 103 (19.3)  99 (19.0) 100 (19.0)
Exercise
　Positive 105 (19.6) 120 (23.0) 101 (19.2) 0.247
　Negative 430 (80.4) 402 (77.0) 426 (80.8)
Adiponectin level of tertile 1,  ＜5.1µg/mL; Adiponectin level of tertile 2,  5.1-7.3µg/mL; Adiponectin level of tertile 3,  ｧ7.4µg/mL;  
Numbers in parentheses are percentages.  Exercise: exercise for more than 30min at a time and more than twice a week (exercise posi-
tive) and less than that (exercise negative).
＄: the Kruskal-Wallis rank sum test was used.
tion with BMI at both the baseline and the endpoint.  
Adiponectin levels,  on the other hand,  showed a sig-
niﬁcant negative association with BMI at both the 
baseline and the endpoint.  Correlation coeﬃcients 
were 0.648 (p＜0.001) between leptin and baseline 
BMI,  and －0.381 (p＜0.001) between adiponectin and 
baseline BMI.
　 Leptin levels showed a signiﬁcant negative rela-
tionship with change in BMI over 3 years in a dose-
response manner,  while adiponectin levels showed a 
signiﬁcant positive relationship.
　 Results of analysis of covariance for diﬀer-
ence in change in BMI over three years.
ANCOVA was carried out to examine the association 
of leptin and adiponectin levels with change in BMI 
over 3 years,  adjusting for age (continuous variable),  
BMI at baseline,  smoking status,  drinking status,  and 
exercise.  The results are shown in Table 5.
　 With leptin,  tertile 1 showed a signiﬁcantly greater 
increase in BMI (adjusted diﬀerence in change in BMI
＝0.178kg/m2,  95ｵ CI: 0.025-0.331kg/m2) over three 
years when tertile 3 was regarded as the reference.
　 With adiponectin,  when tertile 1 was regarded as 
the reference,  no signiﬁcant adjusted diﬀerence in 
change of BMI over 3 years was observed between 
tertile 3 and tertile 1 (adjusted diﬀerence in change in 
BMI＝0.099kg/m2,  95ｵ CI: －0.034-0.231kg/m2),  
or between tertile 2 and tertile 1.
Discussion
　 Leptin acts on the hypothalamus to regulate appe-
tite and energy expenditure [3].  In animal models,  
leptin deﬁciency results in severe obesity that is 
reversed by exogenous leptin administration [3].  
However,  previous epidemiological studies showed that 
leptin levels were signiﬁcantly positively associated 
with BMI,  suggesting that obese individuals had leptin 
resistance [3,  10-12].  Previous prospective studies 
on leptin levels and subsequent weight change pro-
duced inconsistent results [10-15].  Chessler et al.  
found that relatively increased leptin levels are sig-
niﬁcantly associated with greater subsequent gains in 
weight and adiposity [10].  Chu et al.  also reported 
that higher leptin levels were signiﬁcantly associated 
with 4-year weight gain among overweight men,  but 
not among normal-weight men [11].  In some studies,  
no signiﬁcant association between leptin levels and 
subsequent weight change was observed [12-14].  One 
study found that relatively low leptin levels may play 
a role in the development of obesity in Pima Indians,  
who have an extremely high prevalence of obesity and 
diabetes mellitus type 2 [15].
　 The present results for leptin were inconsistent 
with previous studies that showed that leptin levels 
were either signiﬁcantly associated with subsequent 
weight gain or were not associated with subsequent 
weight change.  Heterogeneity between our results and 
these previous studies may be attributed in part to 
diﬀerences in average BMI and in leptin resistance in 
the subjects studied.  Most of these previous studies 
were conducted in the US,  where the proportions of 
overweight and obese individuals were reported to be 
69.2ｵ and 35.9ｵ,  respectively,  among adults aged 
20 or over [19].  The present subjects,  whose pro-
portions of overweight and obese individuals were 
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Table 5　 Results of analysis of covariance for diﬀerences in change in BMI over three years
Variables
Adjusted diﬀerence in change in BMI (kg/m2)
P value
Diﬀerence in change in BMI (95% CI)
Leptin levels
　Tertile 1 (＜2.1ng/mL) 0.178 ( 0.025-0.331) 0.023
　Tertile 2 (2.1-3.3ng/mL) 0.023 (－0.106-0.153) 0.773
　Tertile 3 (ｧ3.4ng/mL) 0 (Reference)
Adiponectin levels
　Tertile 1 (＜5.1µg/mL) 0 (Reference)
　Tertile 2 (5.1-7.3µg/mL) 0.082 (－0.045-0.210) 0.206
　Tertile 3 (ｧ7.4µg/mL) 0.099 (－0.034-0.231) 0.145
adjusted for age (continuous variable),  smoking status,  drinking status,  exercise,  and BMI at baseline.
BMI,  body mass index; CI,  conﬁdence interval.
31.1ｵ and 3.6ｵ,  have a much lower average BMI 
than those of the previous studies.  Chu et al.  [21] 
and Murakami et al.  [22] found that leptin levels were 
signiﬁcantly associated with physical activity and 
dietary factors,  which,  they suggested,  might increase 
leptin sensitivity,  leading in turn to a subsequent 
decline in leptin production through unknown feedback 
mechanisms.  Chu et al.  reported that increased 
physical activity is associated with lower leptin levels 
and that fat intake was found to be positively related 
to leptin levels with marginal signiﬁcance among nor-
mal-weight men [21].  Murakami et al.  indicated that 
the intake of dietary ﬁber,  vegetables and pulses was 
signiﬁcantly inversely associated with leptin levels 
among young Japanese women [22].  Winnicki et al.  
showed that a ﬁsh-rich diet is associated with lower 
leptin levels in the population of Tanzania,  Africa 
[23].  Japanese consume much more ﬁsh and pulses,  
and less fat than Americans [24].  Therefore,  one 
possible explanation is that,  in our subjects with the 
highest leptin levels,  leptin can suppress weight gain 
because although they are overweight or obese,  and 
therefore have some leptin resistance,  they neverthe-
less retain more sensitivity to leptin than Americans.
　 Adiponectin is exclusively secreted by adipocytes 
and is the most abundant adipose tissue-derived pro-
tein [4].  Adiponectin levels in humans are lower in 
obese subjects than in the non-obese,  and in patients 
with coronary artery disease,  metabolic syndrome or 
diabetes mellitus type 2 than in healthy subjects [4,  
6,  8,  25].  A recent study shows that adiponectin 
stimulates AMP-activated protein kinase in the hypo-
thalamus and increases food intake [9].  The funda-
mental role of adiponectin is presumed to be to pre-
serve an adequate fat reserve [9].  Adiponectin may 
have weight-regulating functions.
　 Three previous studies showed no signiﬁcant asso-
ciation between adiponectin levels and subsequent 
weight change [14,  17,  18].  Vozarova et al.  studied 
Pima Indians,  who have an extremely high prevalence 
of obesity and diabetes mellitus type 2 [17],  and 
Bennett et al.  studied Afro-Jamaicans [18]; these 2 
studies had relatively small numbers of subjects.  
Langenberg et al.  studied white men and women aged 
60 to 91,  most of whom had spontaneous weight loss 
[14].  Hivert et al.  found that higher adiponectin lev-
els were associated with signiﬁcantly greater weight 
gain among healthy women [16].  The present results 
indicated that higher adiponectin levels were associ-
ated with greater weight gain,  but this association was 
attenuated and did not show statistical signiﬁcance 
after adjusting for age,  baseline BMI,  smoking status,  
drinking status and exercise.  The diﬀerence between 
our results and Hivertʼs may be attributed to gender 
and ethnicity.  Adiponectin levels in women are gener-
ally higher than in men [26],  and women with higher 
adiponectin levels may therefore have a greater capac-
ity to accumulate fat than men with higher adiponectin 
levels.  The impact of adiponectin on subsequent 
weight change may,  for genetic reasons,  be greater in 
Caucasians than in Japanese.
　 Our study had a prospective design and a large 
number of subjects,  but has certain limitations.  One 
limitation of the present study was the lack of infor-
mation on whether the subjects had tried to make 
voluntary changes in food intake to reduce their 
weight,  though attempts to lose weight are common 
among obese men but rarely successful.  Another limi-
tation was that our study did not investigate genetic 
factors.  We conducted a reanalysis,  excluding men 
with a BMI of more than 30 who may have some 
genetic factors for obesity,  but the results showed,  as 
before,  that subjects with the lowest leptin levels had 
a signiﬁcantly greater increase in BMI over three 
years than those with the highest leptin levels.  More 
deﬁnite conclusions might be reached in future 
research by using a robust analytical approach,  for 
example,  ﬁxed-eﬀect analysis.
　 In conclusions,  the subjects with the lowest leptin 
levels showed a signiﬁcantly greater increase in BMI 
over 3 years than those with the highest leptin levels 
even after adjusting for age,  baseline BMI,  smoking 
status,  drinking status and exercise.  This ﬁnding 
suggests that higher leptin levels could suppress 
weight gain in Japanese male workers,  who have a low 
prevalence of obesity,  and supports the theory that 
leptin is one of the biological systems that maintain 
homeostatic control of body weight [3].
　 The subjects with the highest adiponectin levels 
showed a greater increase in BMI over 3 years than 
those with the lowest adiponectin levels,  but this 
association was not statistically signiﬁcant after 
adjusting for confounding factors.  The present study 
thus cannot prove the hypothesis that Japanese men 
with higher adiponectin levels have a greater capacity 
to accumulate fat than those with lower adiponectin 
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